Compounds  →  Pyrilamine

Separation of Pyrilamine

HPLC Separation of Drugs


Mixed-mode chromatography allows to separate various hydrophobic and hydrophilic drugs in one HPLC method. Presence of at least two mechanism of retention allows adjust selectivity of separation by changing three parameters: amount of acetonitrile, buffer concentration and buffer pH. Seven common drugs are separated on an Obelisc R trimodal HPLC column in gradient method. Method provides alternative selectivity to traditional reversed-phase chromatography. Operational range in which basic compounds are retained the most is from pH 3 to 5. At higher pH, longer retention can be achieved. Mixed-mode chromatography provides longer retention and better peak shapes for basic and acidic analytes. Method can be used in analysis of drugs and pharmaceuticals.



Application Analytes:

Dextromethorphan
Doxylamine
Norephedrine
Norphenylephrine
Pseudoephedrine (PSE)
Pyrilamine
Trimipramine

Application Detection:

UV Detection

Comparison of the Separation of Polar Drugs on Obelisc R and Zorbax SB-AQ


Common hydrophobic basic and hydrophilic basic drugs are separated by mixed-mode chromatography with greater selectivity and resolution than traditional reversed-phase column. Drugs are retained by combination of reversed-phase and cation-exchange mechanisms. Retention time is controlled by amount of acetonitrile, buffer concentration and buffer pH. Available detection techniques are based on buffer selection and include UV, Evaporative Light-Scattering Detector (ELSD), Corona (CAD), LC/MS, etc. This HPLC method can be adopted as general approach for analysis of drugs and pharmaceuticals.



Application Analytes:

Dextromethorphan
Doxylamine
Norephedrine
Norphenylephrine
Pseudoephedrine (PSE)
Pyrilamine
Trimipramine

Application Detection:

UV Detection

HPLC Analysis of Basic Drugs and Acidic Counter-Ions by Mixed-Mode Chromatography



Majority of the drugs in pharmaceutical industries are administered in a salt form. The presence of two counter-ions very often requires two methods. The nature of these counterparts in drugs can be: inorganic cation and organic acid, inorganic anion and organic base, and organic cation and organic anion. Based on the property of molecules the stoichiometry can be different also. The task of simultaneous quantitation of counter-ions can be achieved by using mixed-mode columns. The general approach for analysis is based on properties of corresponding counter-ions. Hydrophobic basic drugs, like dextromethorphan, verapamil, trimipramine, and corresponding acidic counter-ions (chloride, chlorate, bromide, bromate, perchlorate, maleate, fumarate,tartrate, succinate, phosphate, citrate, benzosulfonate, toleuensulfonate) can be separated and quantitated in the same run on reversed-phase anion-exchange column. Basic hydrophobic drugs are retained by reversed-phase mechanism, and counter-ion are retained by reversed-phase and anion-exchange mechanism. Some polar counter-ions are retained only by anion-exchange mechanism. Retention time and selectivity of HPLC separation of drugs and counter-ions can be achieved by changing amount of acetonitrile and amount of ions in the mobile phase. Detection technique depends on the properties of counter-ions. In case of low or no UV activity, ELSD can be employed if counter-ion forms non-volatile salt wit mobile phase additive (ammonium formate). This HPLC method can be used for simultaneous quantitation of other basic drugs and counter-ions. Presence of two mechanisms of retention allows to control retention times of drug and counter-ion independently, and even change order of elution when necessary.

Application Analytes:

Citric Acid
Bromide
Chloride
Chlorate
Perchlorate
Maleic Acid
Fumaric Acid
Tartaric Acid
Succinic Acid
Phosphoric Acid
Dextromethorphan
Verapamil
Pyrilamine
Benzenesulfonic Acid
p-Toluenesulfonic Acid (PTSA)

Application Detection:

UV Detection
ELSD/MS Detection

SIELC Technologies | 65 East Palatine Road, Suite 221, Prospect Heights, IL USA 60070 | Tel: (847) 229-2629 Fax: (847) 655-6079 | Email: mail@sielc.com | sitemap
Copyright © SIELC Technologies. 2002-2012